TCB Self-Monitoring in Healthy Term and Near-Term Neonates

Neonatal-Infant Brain and Behavior Development Network

Status: Completed

Conditions: Hyperbilirubinemia, Neonatal

Treatments: Device: Transcutaneous bilirubin level monitoring

Study type: Observational

Funder types: Other; NETWORK

Identifiers

NCT06645158

Multi-TCB

Details and patient eligibility

About

The goal of this observational study is to monitor the transcutaneous bilirubin (TCB) level in healthy near-term and full-term neonates from birth to 30 days of age across China. The main question it aims to answer is:

Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants Compare the changing trend of TCB among different areas in China Compare the changing trend of TCB among different gestational groups in China

Enrollment: 220,950 patients

Sex: All

Ages: Under 30 days old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Gestational age >=35wk; did not admitted to hospital for any reason Less than 30 days of age

Exclusion criteria

Accept phototherapy within 60h of age

Trial design

220,950 participants in 1 patient group

normal neonate

Description:

gestational age \>= 35wk; did not admitted to hospital for any reason; did not need phototherapy within 60h after birth;

Treatment:

Device: Transcutaneous bilirubin level monitoring